Events

Biowaste to Biologics: Bacteriophage Therapeutic Platforms

Roderick Slavcev

Associate Professor, University of Waterloo School of Pharmacy

What Is Aducanumab and Who Is Francis Kathleen Oldham Kelsey? Where Things Go Wrong in the Approval Process for New Drugs

David B. Hogan

Professor, Medicine, Clinical Neurosciences, and Community Health Sciences, Faculty of Medicine, University of Calgary

Novel Pyrimidine and Purine Derivatives as Inhibitors of Amyloid Beta Aggregation

Arash Shakeri, PhD Candidate

School of Pharmacy, University of Waterloo

The Evaluation of Bacteriophage M13-Based Gene Delivery in the Targeted Treatment of Alzheimer’s Disease

Jesse St. Jean, PhD Candidate

School of Pharmacy, University of Waterloo

Green Coated Gold Nanoparticles as an Adjuvant for Prostate Cancer Therapy

Mohamed Aborig, PhD Candidate

School of Pharmacy, University of Waterloo

Advancing knowledge of breastfeeding infant exposure to maternal medications through physiologically based pharmacokinetic (PBPK) modeling: An example with cannabidiol (CBD)

Cindy Hoi Ting Yeung, PhD Candidate

School of Pharmacy, University of Waterloo

Heba Alattas, PhD Candidate

PhD Candidate, School of Pharmacy, University of Waterloo

The Graduate Studies Seminar series takes place in the fall and winter terms, and features presentations by invited guest lecturers as well as by our own faculty members, post-doctoral fellows and PhD candidates. Regular attendance at the Graduate Studies Seminars is a milestone requirement for all MSc and PhD Students in the School of Pharmacy; all members of the School of Pharmacy are welcome to attend.  

The associations between insulin, hypoglycemia, and dementia: Combating threats to validity in a series of population-based cohort studies

Wajd Alkabbani, PhD Candidate

School of Pharmacy, University of Waterloo

Influenza Vaccine Effectiveness against Laboratory-Confirmed Influenza among Patients with Cardiovascular Hospitalization.

Razan Amoud, PhD Candidate

School of Pharmacy, University of Waterloo

Estimating the economic burden of hemophilia A in Ontario using health administrative data